Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

We do expect COVID vaccines may be updated with a new formula next fall for the 2025-2026 season but not for the current ...

This latest study shows the vaccine does not increase the risk of having a baby born with major birth defects.

Laredo remembers its COVID-19 journey, honoring frontline workers, community efforts and key lessons for future health crises ...

The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, creating a significant health risk for vulnerable populations.

Five young volunteers here have been deliberately exposed to the Covid-19 virus in the country's first human challenge study, ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Research offering unprecedented insights into global vaccine distribution patterns has found significant disparities in COVID ...